HI
ABBV icon

Human Investing’s AbbVie ABBV Stock Holding History

Human Investing’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Sell
9,340
-129
-1% -$27.8K 0.3% 28
2026
Q1 		$2.06M Sell
9,469
-667
-7% -$148K 0.3% 28
2025
Q4 		$2.32M Sell
10,136
-644
-6% -$147K 0.33% 28
2025
Q3 		$2.5M Sell
10,780
-2,251
-17% -$458K 0.37% 26
2025
Q2 		$2.42M Sell
13,031
-42
-0.3% -$7.81K 0.38% 26
2025
Q1 		$2.74M Sell
13,073
-352
-3% -$68.4K 0.48% 26
2024
Q4 		$2.39M Sell
13,425
-297
-2% -$54.6K 0.42% 26
2024
Q3 		$2.71M Buy
13,722
+74
+0.5% +$13.8K 0.49% 27
2024
Q2 		$2.34M Sell
13,648
-1,139
-8% -$189K 0.46% 29
2024
Q1 		$2.69M Sell
14,787
-52
-0.4% -$8.96K 0.54% 27
2023
Q4 		$2.3M Sell
14,839
-747
-5% -$109K 0.5% 27
2023
Q3 		$2.32M Buy
15,586
+57
+0.4% +$8.37K 0.54% 24
2023
Q2 		$2.09M Sell
15,529
-2,920
-16% -$428K 0.48% 26
2023
Q1 		$2.94M Sell
18,449
-1,404
-7% -$215K 0.71% 21
2022
Q4 		$3.21M Sell
19,853
-3,154
-14% -$484K 0.82% 18
2022
Q3 		$3.09M Sell
23,007
-683
-3% -$98K 0.79% 20
2022
Q2 		$3.63M Sell
23,690
-738
-3% -$113K 0.88% 20
2022
Q1 		$3.96M Sell
24,428
-5,807
-19% -$844K 0.88% 20
2021
Q4 		$4.09M Sell
30,235
-535
-2% -$63.2K 0.98% 19
2021
Q3 		$3.32M Sell
30,770
-586
-2% -$67K 0.78% 19
2021
Q2 		$3.53M Buy
31,356
+214
+0.7% +$24.1K 0.86% 19
2021
Q1 		$3.37M Sell
31,142
-3,705
-11% -$396K 0.86% 18
2020
Q4 		$3.73M Sell
34,847
-8,585
-20% -$825K 1.06% 17
2020
Q3 		$3.8M Sell
43,432
-3,657
-8% -$344K 1.25% 13
2020
Q2 		$4.62M Sell
47,089
-3,067
-6% -$270K 1.63% 12
2020
Q1 		$3.82M Sell
50,156
-6,872
-12% -$585K 1.65% 10
2019
Q4 		$5.05M Sell
57,028
-1,053
-2% -$87.4K 1.65% 9
2019
Q3 		$4.4M Sell
58,081
-95
-0.2% -$6.51K 1.56% 10
2019
Q2 		$4.23M Sell
58,176
-462
-0.8% -$36.3K 1.54% 10
2019
Q1 		$4.73M Buy
58,638
+28,300
+93% +$2.32M 1.77% 9
2018
Q4 		$2.8M Buy
+30,338
New +$2.67M 1.17% 19

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Human Investing's ABBV Position: Q2 2026 in Review

Human Investing reduced its AbbVie (ABBV) stake by 1.4% in Q2 2026, selling an estimated $27.8K and leaving 9,340 shares worth $2.35M. The position accounts for 0.3% of the portfolio, ranked #28.

Human Investing first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $5.05M in Q4 2019. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Human Investing held 9,340 shares of AbbVie worth $2.35M as of Q2 2026.
  • Human Investing sold 129 AbbVie shares in Q2 2026, an estimated $27.8K.
  • AbbVie made up 0.3% of Human Investing's portfolio in Q2 2026, its #28 holding.
  • Human Investing first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
  • Human Investing's AbbVie position peaked at $5.05M in Q4 2019.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Human Investing's 13F filing for Q2 2026, filed 20 Jul 2026.